CopyFind
Hyrimoz
medicine 📍 EU

Hyrimoz

Analogs of Hyrimoz

Find cheaper analogs and generic equivalents for Hyrimoz.

Ingredients

Active Ingredient: adalimumab


Product Overview

About Hyrimoz

Hyrimoz is a solution for injection under the skin.

What it is used for

Not available in the provided information.

How it is used

Hyrimoz is usually given every 2 weeks. The dose and frequency of injection depends on the condition to be treated and the dose for a child is calculated according to the child’s weight. After training, patients or their carers may inject Hyrimoz if their doctor considers it appropriate. Hyrimoz can only be obtained by prescription and treatment must be started and supervised by a doctor who has experience in the treatment of the diseases for which Hyrimoz is used. Eye specialists treating uveitis should also take advice from doctors who have experience of using Hyrimoz.

How it works

The active substance in Hyrimoz, adalimumab, is a monoclonal antibody (a type of protein) that has been designed to recognise and attach to a substance in the body called tumour necrosis factor (TNF). TNF is involved in causing inflammation and is found at high levels in patients with the diseases that Hyrimoz is used to treat. By attaching to TNF, adalimumab blocks its activity, thereby reducing inflammation and other symptoms of the diseases.

Active substance: adalimumab

Source: EMA EPAR

Visitor ratings

Help others by rating how useful this product page is.

No ratings yet — be the first.

Similar Products & Analogs

HULIO

Active: ADALIMUMAB

Match: 100% Compare →
HUMIRA

Active: ADALIMUMAB

Match: 100% Compare →
IDACIO

Active: ADALIMUMAB

Match: 100% Compare →
ЮФЛІМА

Active: Adalimumab

Match: 100% Compare →
ХУМІРА

Active: Adalimumab

Match: 100% Compare →
Hefiya

Active: adalimumab

Match: 100% Compare →
HADLIMA

Active: ADALIMUMAB

Match: 100% Compare →
HYRIMOZ

Active: ADALIMUMAB

Match: 100% Compare →
YUFLYMA

Active: ADALIMUMAB

Match: 100% Compare →
ХАДЛІМА

Active: Adalimumab

Match: 100% Compare →
Imraldi

Active: adalimumab

Match: 100% Compare →
Kromeya

Active: adalimumab

Match: 100% Compare →